相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mining Naive Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility
Haiyong Peng et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs
Julian Andreev et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation
Nikolas Stefan et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
K. Roarty et al.
ONCOGENE (2017)
Ror2, a Developmentally Regulated Kinase, Is Associated With Tumor Growth, Apoptosis, Migration, and Invasion in Renal Cell Carcinoma
Chun-ming Yang et al.
ONCOLOGY RESEARCH (2017)
Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis
Claire Henry et al.
ONCOTARGET (2017)
Ror2 Signaling and Its Relevance in Breast Cancer Progression
Michaela Bayerlova et al.
FRONTIERS IN ONCOLOGY (2017)
Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
John M. Lambert et al.
ADVANCES IN THERAPY (2017)
Transpo-mAb display: Transposition-mediated B cell display and functional screening of full-length IgG antibody libraries
Lorenz Waldmeier et al.
MABS (2016)
High-Throughput Screening for Internalizing Antibodies by Homogeneous Fluorescence Imaging of a pH-Activated Probe
Thilo Riedl et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Ror2 as a Therapeutic Target in Cancer
Zufan Debebe et al.
PHARMACOLOGY & THERAPEUTICS (2015)
High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
Jianfei Huang et al.
SCIENTIFIC REPORTS (2015)
Immunogenicity of Antibody Drug Conjugates: Bioanalytical Methods and Monitoring Strategy for a Novel Therapeutic Modality
M. Benjamin Hock et al.
AAPS JOURNAL (2015)
Human Antibody Production in Transgenic Animals
Marianne Brueggemann et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2015)
Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency
Roger R. Beerli et al.
PLOS ONE (2015)
A Cell-Based Internalization and Degradation Assay with an Activatable Fluorescence-Quencher Probe as a Tool for Functional Antibody Screening
Yan Li et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer
Haijun Mei et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery
E-Chiang Lee et al.
NATURE BIOTECHNOLOGY (2014)
Retrocyte Display® technology: Generation and screening of a high diversity cellular antibody library
Ekaterina Breous-Nystrom et al.
METHODS (2014)
The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis
Caroline E. Ford et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Receptor Tyrosine Kinase-like Orphan Receptor 2 (Ror2) Expression Creates a Poised State of Wnt Signaling in Renal Cancer
Neal R. Rasmussen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Review of Antibody-Drug Conjugates, Methods in Molecular Biology series
Alain Beck
mAbs (2013)
A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties
Thomas Tiller et al.
MABS (2013)
Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
Michael Ritchie et al.
MABS (2013)
Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9
Javier Chaparro-Riggers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour
Badreddin Edris et al.
JOURNAL OF PATHOLOGY (2012)
ROR1 and ROR2 in human malignancies: potentials for targeted therapy
Guilly Rebagay et al.
FRONTIERS IN ONCOLOGY (2012)
Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
Stephen I. Rudnick et al.
CANCER RESEARCH (2011)
Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell Carcinoma
Tricia M. Wright et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Antibody-drug conjugates for cancer: poised to deliver?
Bethan Hughes
NATURE REVIEWS DRUG DISCOVERY (2010)
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
M. P. O'Connell et al.
ONCOGENE (2010)
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
Kazuhito Morioka et al.
CANCER SCIENCE (2009)
Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity
Masaki Kobayashi et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2009)
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
Michael M. Schmidt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
Thomas Tiller et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Isolation of human monoclonal antibodies by mammalian cell display
Roger R. Beerli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ror receptor tyrosine kinases: orphans no more
Jennifer L. Green et al.
TRENDS IN CELL BIOLOGY (2008)
Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2
Hiroyuki Yamamoto et al.
GENES TO CELLS (2007)
Yeast surface display for protein engineering and characterization
S. Annie Gai et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2007)
Isolation of anti-CD22 Fv with high affinity by Fv display on human cells
Mitchell Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Isolating and engineering human antibodies using yeast surface display
Ginger Chao et al.
NATURE PROTOCOLS (2006)
Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes
L Quintieri et al.
CLINICAL CANCER RESEARCH (2005)
Secondary mAb-vcMMAE conjugates are highly sensitive reporters of antibody internalization via the lysosome pathway
K Klussman et al.
BIOCONJUGATE CHEMISTRY (2004)
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
JA Francisco et al.
BLOOD (2003)
The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway
I Oishi et al.
GENES TO CELLS (2003)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells
JD Berry et al.
HYBRIDOMA AND HYBRIDOMICS (2003)
Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development
TM DeChiara et al.
NATURE GENETICS (2000)
Exploiting recombination in single bacteria to make large phage antibody libraries
D Sblattero et al.
NATURE BIOTECHNOLOGY (2000)
分享论文
